课题基金 / 基金详情

A Synthetic Approach to Calyxins and Epicalyxins I and J

A Synthetic Approach to Calyxins and Epicalyxins I and J
萼蛋白和表萼蛋白 I 和 J 的合成方法
批准号:
7126978
负责人:
KEITH Thomas MEAD
金额:
$20.93万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2009-08-31

项目摘要

项目成果

KEITH Thomas MEAD的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):Alpinia blepharocalyx的三种成分calyxin I、calyxin J和epicalyxin J因其对人纤维肉瘤HT-1080和小鼠结肠26-L5癌细胞的体外活性而成为本提案的主题。本研究的长期目标是通过独立合成来验证这些化合物的绝对结构。具体地说,这个建议将集中在这个难题的一部分,即开发一种立体控制的方法,以融合环系统共同的每个化合物。本研究设计分为三个主要部分。在第一部分中,将研究取代的二氢吡喃和n -酰基亚胺之间的杂Diels-Alder反应,从而产生融合的环状双环缩醛。第二节重点讨论了这些[4 + 2]环加合物与各种亲核试剂的路易斯酸环裂解反应。由这些双环缩醛生成的氧羰基离子通过富电子芳香环的亲核加成而产生预期的c -芳基吡喃苷产物。第三部分将集中讨论这种方法在合成中的应用。每个环裂解产物应在四氢吡喃环的C-2上含有一个带有酰胺部分的侧链。将设计一组实验,通过添加具有增强电子吸出能力的基团来逐渐增加该酰胺部分的电子缺乏性。我们假设在Lewis酸环境中,在邻近基团足够稳定的情况下,酰胺功能的单分子解离将导致碳正离子的形成,从而允许从附近的亲核中心进行分子内取代。这一步的目的是提供上述三个成员熔接环系统。这些成分的体外抗癌活性使它们成为治疗人类肿瘤的潜在候选药物。在与校园生物学家的合作下,他们的实验室合成最终将导致确定它们如何杀死癌细胞。利用这些信息,设计出具有更优越和更有选择性的抗癌特性的类似物应该是可能的。
英文摘要
DESCRIPTION (provided by applicant): Three constituents of Alpinia blepharocalyx, namely calyxin I, calyxin J and epicalyxin J, are the subject of this proposal owing to their in vitro activity against human fibrosarcoma HT-1080 and murine colon 26-L5 carcinoma cells. The long-term objective of this research is to verify the absolute structures of these compounds by independent synthesis. Specifically this proposal will focus on one part of the puzzle, that being to develop a stereocontrolled approach to the fused ring system common to each compound. The research design is divided into three major sections. In section one, hetero Diels-Alder reactions between substituted dihydropyrans and N-acyl imines, leading to fused ring bicyclic acetals, will be studied. Section two focuses on Lewis acid ring cleavage reactions of these [4 + 2] cycloadducts with a variety of nucleophiles. The intended C-aryl pyranoside products will arise from nucleophilic addition of electron rich aromatic rings to oxocarbenium ions generated from these bicyclic acetals. The third section will concentrate on the application of this methodology to synthesis. Each product of ring cleavage should contain a side chain on C-2 of the tetrahydropyran ring which bears an amide moiety. A set of experiments will be designed to gradually increase the electron deficiency of this amide moiety by adding groups with increasing electron withdrawing capabilities. We hypothesize that in a Lewis acid environment, and with sufficient stabilization from neighboring groups, unimolecular dissociation of the amide functionality will lead to carbocation formation, allowing intramolecular substitution from a near-by nucleophilic center. This step is designed to provide the aforementioned three-membered fused ring system. The in vitro anti-cancer activity of these constituents makes them potential drug candidates for the treatment of human tumors. In collaboration with biologists on campus, their laboratory synthesis would eventually lead to the determination of how they kill cancer cells. Using this information, the design of analogues with superior and more selective cancer fighting properties should be possible.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/jo901436u
发表时间: 2009-10-02
期刊: The Journal of organic chemistry
影响因子: --
作者: [Cakir SP, Stokes S, Sygula A, Mead KT]
通讯作者: Mead KT
Efficient Assemblage of Complex Biologically-Active Targets Using Donor-Acceptor
  • 批准号:
    8364688
  • 项目类别:
  • 资助金额:
    $33.64万
  • 财政年份:
    2012
  • 负责人:
    KEITH Thomas MEAD
  • 依托单位:
Synthetic Approaches to Blepharocalyxins D and E
  • 批准号:
    6666077
  • 项目类别:
  • 资助金额:
    $13.83万
  • 财政年份:
    2003
  • 负责人:
    KEITH Thomas MEAD
  • 依托单位:
SYNTHESIS OF THE SPIROKETAL SUBUNIT OF REVEROMYCIN A
  • 批准号:
    6473754
  • 项目类别:
  • 资助金额:
    $0.97万
  • 财政年份:
    2000
  • 负责人:
    KEITH Thomas MEAD
  • 依托单位:
SYNTHESIS OF THE SPIROKETAL SUBUNIT OF REVEROMYCIN A
  • 批准号:
    6028231
  • 项目类别:
  • 资助金额:
    $10.43万
  • 财政年份:
    2000
  • 负责人:
    KEITH Thomas MEAD
  • 依托单位:
海外基金